Literature DB >> 18372427

Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress.

Emilie Boncoeur1, Telma Roque, Elise Bonvin, Vinciane Saint-Criq, Monique Bonora, Annick Clement, Olivier Tabary, Alexandra Henrion-Caude, Jacky Jacquot.   

Abstract

Cystic fibrosis is a lethal inherited disorder caused by mutations in a single gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein, resulting in progressive oxidative lung damage. In this study, we evaluated the role of CFTR in the control of ubiquitin-proteasome activity and nuclear factor (NF)-kappaB/IkappaB-alpha signaling after lung oxidative stress. After a 64-hour exposure to hyperoxia-mediated oxidative stress, CFTR-deficient (cftr(-/-)) mice exhibited significantly elevated lung proteasomal activity compared with wild-type (cftr(+/+)) animals. This was accompanied by reduced lung caspase-3 activity and defective degradation of NF-kappaB inhibitor IkappaB-alpha. In vitro, human CFTR-deficient lung cells exposed to oxidative stress exhibited increased proteasomal activity and decreased NF-kappaB-dependent transcriptional activity compared with CFTR-sufficient lung cells. Inhibition of the CFTR Cl(-) channel by CFTR(inh-172) in the normal bronchial immortalized cell line 16HBE14o- increased proteasomal degradation after exposure to oxidative stress. Caspase-3 inhibition by Z-DQMD in CFTR-sufficient lung cells mimicked the response profile of increased proteasomal degradation and reduced NF-kappaB activity observed in CFTR-deficient lung cells exposed to oxidative stress. Taken together, these results suggest that functional CFTR Cl(-) channel activity is crucial for regulation of lung proteasomal degradation and NF-kappaB activity in conditions of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18372427      PMCID: PMC2329829          DOI: 10.2353/ajpath.2008.070310

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  69 in total

1.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism.

Authors:  R Sen; D Baltimore
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line.

Authors:  Isabel Virella-Lowell; John-David Herlihy; Barry Liu; Cecilia Lopez; Pedro Cruz; Chris Muller; Henry V Baker; Terence R Flotte
Journal:  Mol Ther       Date:  2004-09       Impact factor: 11.454

6.  A cystic fibrosis bronchial epithelial cell line: immortalization by adeno-12-SV40 infection.

Authors:  P L Zeitlin; L Lu; J Rhim; G Cutting; G Stetten; K A Kieffer; R Craig; W B Guggino
Journal:  Am J Respir Cell Mol Biol       Date:  1991-04       Impact factor: 6.914

7.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

8.  NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis.

Authors:  William R Franek; Dympna M P Morrow; Hong Zhu; Ivana Vancurova; Veronika Miskolci; Kenta Darley-Usmar; H Hank Simms; Lin L Mantell
Journal:  Free Radic Biol Med       Date:  2004-11-15       Impact factor: 7.376

9.  Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia.

Authors:  Guang Yang; Aida Abate; Adia G George; Yi-Hao Weng; Phyllis A Dennery
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 10.  The ubiquitin system: from basic mechanisms to the patient bed.

Authors:  Aaron Ciechanover; Kazuhiro Iwai
Journal:  IUBMB Life       Date:  2004-04       Impact factor: 3.885

View more
  5 in total

Review 1.  Oxidative stress, autophagy and airway ion transport.

Authors:  Scott M O'Grady
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-10       Impact factor: 4.249

Review 2.  Cystic fibrosis: a mucosal immunodeficiency syndrome.

Authors:  Taylor Sitarik Cohen; Alice Prince
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

3.  Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells.

Authors:  Toni R Bartling; Mitchell L Drumm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

4.  CFTR Regulates the Proliferation, Migration and Invasion of Cervical Cancer Cells by Inhibiting the NF-κB Signalling Pathway.

Authors:  Zhao Wu; Jinke Li; Yi Zhang; Lina Hu; Xue Peng
Journal:  Cancer Manag Res       Date:  2020-06-18       Impact factor: 3.989

5.  Cystic Fibrosis: Systems Biology Analysis from Homozygous p.Phe508del Variant Patients' Samples Reveals Perturbations in Tissue-Specific Pathways.

Authors:  Joice de Faria Poloni; Thaiane Rispoli; Maria Lucia Rossetti; Cristiano Trindade; José Eduardo Vargas
Journal:  Biomed Res Int       Date:  2021-12-02       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.